EUVIMEDEUVIMED entdecken
Open Access

In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer

Jian Xu, Ling Cheng, Sien Ma, Chen Gan, Jiaying Chai, Xinyi Zheng, Longyu Hu, Meiwen Ling, Mingjun Zhang, Bao Zhao, Huaidong Cheng

International Journal of Biological Sciences · 18.02.2026 · 22 (6) · 2950-2969

DOI: 10.7150/ijbs.124937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 18.02.2026. Verfasst von Jian Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, Tuberous Sclerosis Complex 2 Protein, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Conjugating EnzymesTuberous Sclerosis Complex 2 ProteinTriple Negative Breast NeoplasmsHumansAutophagyAnimalsFemaleCRISPR-Cas SystemsUbiquitinationCell Line, TumorMice

Stichwörter der Autor:innen

CRISPR/Cas9PD-1TNBCautophagyubiquitination

Substanzen

Ubiquitin-Conjugating EnzymesTuberous Sclerosis Complex 2 ProteinTSC2 protein, human

Autor:innen und Institutionen

  • Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
  • Department of Traditional Chinese Medicine, The People's Hospital of Pingshan Shenzhen (Pingshan Hospital of Southern Medical University), Shenzhen, Guangdong, China.
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui, China.
  • Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China.
  • Shenzhen Clinical Medical School of Southern Medical University, China.
  • Department of Oncology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Zitieren

APA

Xu, J., Cheng, L., Ma, S., Gan, C., Chai, J., Zheng, X., Hu, L., Ling, M., Zhang, M., Zhao, B., & Cheng, H. (2026). In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer. International Journal of Biological Sciences, 22(6), 2950-2969. https://doi.org/10.7150/ijbs.124937

Vancouver

Xu J, Cheng L, Ma S, Gan C, Chai J, Zheng X, et al. In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer. International Journal of Biological Sciences. 2026;22(6):2950-2969. doi:10.7150/ijbs.124937

BibTeX
@article{Xu2026,
  author = {Xu, Jian and Cheng, Ling and Ma, Sien and Gan, Chen and Chai, Jiaying and Zheng, Xinyi and Hu, Longyu and Ling, Meiwen and Zhang, Mingjun and Zhao, Bao and Cheng, Huaidong},
  title = {In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {2950--2969},
  doi = {10.7150/ijbs.124937}
}
Kostenlos starten →